Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) stock closed at $25.68 on 9/2/25 after a major increase of 16.6%. Moreover, this advance was accompanied by exceptionally high trading volume at 276% of normal. The stock has risen 20.4% during the last week but has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Arrowhead Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Arrowhead Pharmaceuticals has a very low Power Rating of 10 and a very low Appreciation Score of 3, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment